Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
group_1_presentation_1_-_als [2019/02/01 17:28] chens60 [CuATSM] |
group_1_presentation_1_-_als [2019/02/01 21:26] (current) achunaia [Riluzole] |
||
|---|---|---|---|
| Line 2: | Line 2: | ||
| - | <box 40% width centre|> {{ :alsneurons.png?nolink&400 |}}</box| Figure 1. Neuron.> | + | <box 40% width centre|> {{ :alsneurons.png?nolink&400 |}}</box| Figure 1. Motor Neuron.> |
| ====== What is Amyotrophic Lateral Sclerosis (ALS)? ====== | ====== What is Amyotrophic Lateral Sclerosis (ALS)? ====== | ||
| Line 119: | Line 119: | ||
| | | ||
| - | <box 40% width centre|> {{ :playground:advancedriluzole.png?400 |}}</box| Figure 6. Role of Riluzole.> | + | <box 40% width centre|> {{ :playground:advancedriluzole.png?400 |}}</box| Figure 6. The mechanism of Riluzole.> |
| Line 161: | Line 161: | ||
| Bogdanov, M., Brown Jr, R. H., Matson, W., Smart, R., Hayden, D., O’Donnell, H., ... & Cudkowicz, M. (2000). Increased oxidative damage to DNA in ALS patients. Free Radical Biology and Medicine, 29(7), 652-658. | Bogdanov, M., Brown Jr, R. H., Matson, W., Smart, R., Hayden, D., O’Donnell, H., ... & Cudkowicz, M. (2000). Increased oxidative damage to DNA in ALS patients. Free Radical Biology and Medicine, 29(7), 652-658. | ||
| + | |||
| + | Bryson, H. M., Fulton, B., & Benfield, P. (1996). Riluzole. Drugs, 52(4), 549–563. https://doi.org/10.2165/00003495-199652040-00010 | ||
| Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000). El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders, 1(5), 293-299. | Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000). El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders, 1(5), 293-299. | ||
| Line 191: | Line 193: | ||
| Learning, L. (n.d.). Biology for Majors I. Retrieved from https://courses.lumenlearning.com/wm-biology1/chapter/reading- electron-transport-chain/ | Learning, L. (n.d.). Biology for Majors I. Retrieved from https://courses.lumenlearning.com/wm-biology1/chapter/reading- electron-transport-chain/ | ||
| + | |||
| + | Lewerenz, J., & Maher, P. (2015). Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence? Frontiers in Neuroscience, 9. https://doi.org/10.3389/fnins.2015.00469 | ||
| Mitsumoto, H. (1997). Diagnosis and progression of ALS. Neurology, 48(4 Suppl 4), 2S-8S. | Mitsumoto, H. (1997). Diagnosis and progression of ALS. Neurology, 48(4 Suppl 4), 2S-8S. | ||
| Line 199: | Line 203: | ||
| Riluzole Oral : Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD. (n.d.). Retrieved from | Riluzole Oral : Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD. (n.d.). Retrieved from | ||
| https://www.webmd.com/drugs/2/drug-12138/riluzole-oral/details | https://www.webmd.com/drugs/2/drug-12138/riluzole-oral/details | ||
| + | |||
| + | Rothstein, J. D. (1996). Therapeutic horizons for amyotrophic lateral sclerosis. Current Opinion in Neurobiology, 6(5), 679–687. https://doi.org/10.1016/S0959-4388(96)80103-6 | ||
| Seals, R. M., Hansen, J., Gredal, O., & Weisskopf, M. G. (2016). Physical Trauma and Amyotrophic Lateral Sclerosis: A Population-Based Study Using Danish National Registries. //American Journal of Epidemiology,183//(4), 294-301. doi:10.1093/aje/kwv169 | Seals, R. M., Hansen, J., Gredal, O., & Weisskopf, M. G. (2016). Physical Trauma and Amyotrophic Lateral Sclerosis: A Population-Based Study Using Danish National Registries. //American Journal of Epidemiology,183//(4), 294-301. doi:10.1093/aje/kwv169 | ||
| Line 206: | Line 212: | ||
| Swash, M. (2018). Physical activity as a risk factor in ALS. //Journal of Neurology, Neurosurgery & Psychiatry,89//(8), 793-793. doi:10.1136/jnnp-2018-318147 | Swash, M. (2018). Physical activity as a risk factor in ALS. //Journal of Neurology, Neurosurgery & Psychiatry,89//(8), 793-793. doi:10.1136/jnnp-2018-318147 | ||
| + | |||
| + | Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., … Dingledine, R. (2010). Glutamate Receptor Ion Channels: Structure, Regulation, and Function. Pharmacological Reviews, 62(3), 405–496. https://doi.org/10.1124/pr.109.002451 | ||
| What is ALS? - ALS Society of Canada. (n.d.). Retrieved from https://www.als.ca/about-als/what-is-als/ | What is ALS? - ALS Society of Canada. (n.d.). Retrieved from https://www.als.ca/about-als/what-is-als/ | ||
